Yahoo! FinanceHome - Yahoo! - Help

Market Guide

[ Stock Screener | Company & Fund Index | Financial Glossary ]

Profile - Immucor, Inc. (NasdaqNM:BLUD)
As of 31-Aug-2001
Enter symbol:
symbol lookup

 
More Info: Quote | Chart | News | Profile | Research | SEC | Msgs | Insider | Financials
Location
3130 Gateway Drive, PO Box 5625
Norcross, GA 30091
Phone: (770) 441-2051
Fax: (770) 441-3807
Email: cvinson@immucor.com
Employees (last reported count): 424
Financial Links
 ·Top Institutional Holders
 ·Top Mutual Fund Holders
 ·Historical Quote Data
 ·Raw SEC Filings at sec.gov
Competitors:
 ·Sector: Healthcare
 ·Industry: Medical Equipment & Supplies
Company Websites
 ·Home Page
 ·Employment
 ·Products & Services
 ·Yahoo! Category

 ·Search Yahoo! for related links...

Ownership
·Insider and 5%+ Owners: 33%
·Institutional: 13% (19% of float)
(29 institutions)
·Net Inst. Selling: 37.0K shares (+4.10%)
(prior quarter to latest quarter)
More From Market Guide
 ·Highlights
 ·Performance
 ·Ratio Comparisons
Business Summary
Immucor Inc. develops, manufactures and sells a complete line of reagents and automated systems used primarily by hospitals, clinical laboratories and blood banks in a number of tests performed to detect and identify certain properties of the cell and serum components of human blood prior to blood transfusion. During fiscal 1999, the Company implemented its strategic plans to consolidate the United States blood bank market, leaving Immucor and Ortho Clinical Diagnostics as the only two companies offering a complete line of blood banking reagents in the United States, and to strengthen Immucor's direct presence in Europe and Canada. Immucor is part of the immunohematology industry, which generally seeks to prevent or cure certain diseases or conditions through the transfusion of blood and blood components.
More from Market Guide: Expanded Business Description

Financial Summary
Immucor, Inc. develops, manufactures and sells a complete line of reagents and automated systems used primarily by hospitals, clinical laboratories and blood banks to detect and identify properties in the human blood. For the nine months ended 2/28/01, revenues fell 13% to $50.8 million. Net loss totalled $6.7 million vs. an income of $3.5 million. Results reflect delays in customer accepting instruments and a $3.3 million loss on impairment of goodwill.
More from Market Guide: Significant Developments

Officers[Insider Trade Data]
FY2000 Pay

Edward Gallup, 61
Chairman, Pres and CEO
$268K
Patrick Waddy, 43
Pres of Dominion Biologicals Limited and European Fin. Director
88K
Gioacchino De Chirico, 47
Director; Director of European Operations and Pres of Immucor Italia S.r.l.
214K
Ralph Eatz, 56
Sr. VP of Operations
250K
Steven Ramsey, 51
VP, CFO, Sec.
186K
Dollar amounts are as of 31-May-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc..
More from Market Guide on Officers & Directors:
Expanded List, Bios, Compensation, Options
Statistics at a Glance -- NasdaqNM:BLUDAs of 31-Aug-2001
Price and Volume
52-Week Low
on 29-Dec-2000
$2.00 
Recent Price$2.80 
52-Week High
on 20-Nov-2000
$5.938
Beta0.15 
Daily Volume (3-month avg)13.8K
Daily Volume (10-day avg)15.0K
Stock Performance
[one-year price graph]
big chart [1d | 5d | 3m | 6m | 1y | 2y | 5y | max]
52-Week Change-27.2%
52-Week Change
relative to S&P500
-2.3%
Share-Related Items
Market Capitalization$20.4M
Shares Outstanding7.28M
Float4.90M
Dividends & Splits
Annual Dividendnone 
Last Split: 3 for 2 on 22-July-1991
Per-Share Data
Book Value (mrq)$4.44 
Earnings (ttm)-$1.00 
Earnings (mrq)-$0.80 
Sales (ttm)$9.32 
Cash (mrq)$0.40 
Valuation Ratios
Price/Book (mrq)0.63 
Price/EarningsN/A 
Price/Sales (ttm)0.30 
Income Statements
Sales (ttm)$68.9M
EBITDA (ttm)-$2.52M
Income available to common (ttm)-$7.35M
Profitability
Profit Margin (ttm)-10.7%
Operating Margin (ttm)-6.4%
Fiscal Year
Fiscal Year EndsMay 31
Most recent quarter28-Feb-2001
Management Effectiveness
Return on Assets (ttm)-7.13%
Return on Equity (ttm)-18.83%
Financial Strength
Current Ratio (mrq)0.75 
Debt/Equity (mrq)1.48 
Total Cash (mrq)$2.91M
Short Interest
As of 8-Aug-2001
Shares Short1,000 
Percent of Float0.0%
Shares Short
(Prior Month)
4,000 
Short Ratio0.08 
Daily Volume13.0K
See Profile Help for a description of each item above;   K = thousands;   M = millions;   mrq = most-recent quarter;   ttm = trailing twelve months;   (as of 28-Feb-2001)

Market Guide offers more in-depth Company Research, Stock Screening, and Hottest Stocks and Industries on over 10,000 U.S. Equities.


Copyright © 2001 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Company information Copyright Market Guide. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.